That's the plan buddy. They don't want a mention at this point. Our tablet and nasal spray will be a big deal, the longer we can remain quiet the more dramatic our entrance into the world of pain relief will become. With hardly any trials ongoing (little do they know)..We are quietly finishing up our phase 1 fibro this quarter, followed by phase 2 3rd/4th quarter this year, with phase 1 nasal spray 3rd quarter this year also. With all the investor concerns about being behind with our studies we may actually be one of the front runners in pain med development.
News 
Market Data 
Discover 
